Actionable news
0
All posts from Actionable news
Actionable news in RLYP: RELYPSA Inc,

Relypsa: June Numbers Matter

After the close, Relypsa (RLYP) reported the June 2016 prescriptions for Veltassa. The biotech reported the following numbers for June with the associated growth rate from May:

  • New patients - free starter: 1,531, up 11%
  • Outpatient prescriptions: 1,723, up 40%
  • Hospital: 392, up 42%

The numbers confirm that pent up demand exists for a solution to...


More